StockNow
Calendar
Log in
U.S. Markets

Eli Lilly's (LLY) EloraTZP delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes

StockNow breaking-news AI analysis

The headline reports greater weight loss and A1C reduction with EloraTZP versus tirzepatide 15 mg, but the retrieved record has no supporting article body.

1 stocks
LLYEli Lilly & Co.$1,185.02Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Economy

US PCE Price Index (Aug MM) 0.3% vs. Exp. 0.4% (Prev. 0.1%)

U.S. Economy

US Core PCE Index (Aug MM) 0.2% vs. Exp. 0.3% (Prev. 0.1%)

U.S. Economy

US Real Personal Spending (Aug MM) 0.6% (Prev. 0.1%)